Indaptus Therapeutics Files 8-K
Ticker: INDP · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1857044
| Field | Detail |
|---|---|
| Company | Indaptus Therapeutics, INC. (INDP) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Indaptus Therapeutics filed a routine 8-K, no major news.
AI Summary
Indaptus Therapeutics, Inc. filed an 8-K on June 11, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing does not contain specific details on the vote or financial figures but indicates the company is operating under its standard reporting requirements.
Why It Matters
This filing indicates that Indaptus Therapeutics is fulfilling its regulatory obligations by submitting required reports to the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting routine matters and does not disclose any new material information or significant events.
Key Players & Entities
- Indaptus Therapeutics, Inc. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
- June 11, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 3 Columbus Circle (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text.
What are the key financial statements being filed?
The filing states that financial statements are being filed, but the specific content or details of these statements are not included in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K was on June 10, 2025.
What is the principal executive office address for Indaptus Therapeutics, Inc.?
The principal executive office address is 3 Columbus Circle, 15th Floor, New York, New York 10019.
What is the IRS Employer Identification Number for Indaptus Therapeutics, Inc.?
The IRS Employer Identification Number for Indaptus Therapeutics, Inc. is 86-3158720.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Indaptus Therapeutics, Inc. (INDP).